Studies suggest that IPF accounts for 29-48 per cent of diffuse parenchymal lung disease (DPLD) cases in Indian hospitals. Factors such as air pollution, occupational exposures, biomass fuel ...

Studies suggest that IPF accounts for 29-48% of diffuse parenchymal lung disease (DPLD) cases in Indian hospitals. Factors such as air pollution, occupational exposures, biomass fuel inhalation, and ...

Studies suggest that IPF accounts for 29-48% of diffuse parenchymal lung disease (DPLD) cases in Indian hospitals. Factors such as air pollution, occupational exposures, biomass fuel inhalation ...

Heymach reported that the safety profile of zongertinib was consistent across cohorts 1, 3, and 5, including no instances of interstitial lung disease. “In patients with TKD [HER2] mutations [in ...

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3 PH in the most recent classification system. Prevalence of these diseases is increasing over time, creating a ...

Various forms of diffuse parenchymal lung disease have been proposed as potential consequences of severe COVID‑19. We describe the clinical, radiological and histological findings of patients with ...

Children diagnosed with interstitial lung disease (ILD) are now more likely to survive ... The most common diagnoses included diffuse parenchymal lung diseases in the following categories: B1 ...

Imatinib is under clinical development by Aerami Therapeutics and currently in Phase I for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, Phase I drugs for ...

Cancer and cardiovascular (CV) drugs may be linked to a large proportion of drug-induced interstitial lung disease (ILD ... that fell under 3 MEDdra High Level Terms: parenchymal lung disorders (ie, ...

Screening for preclinical parenchymal lung disease in rheumatoid arthritis ... for the detection of interstitial lung disease in adults with early diffuse cutaneous systemic sclerosis.

1 State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, National Center for Respiratory ... imaging manifestations of diffuse lung parenchymal ...